Feedback PLC (FDBK)

Industry Health Information Services


This stock can be held in an Investment ISA and an Investment Account
Sell

20.00p

Buy

21.00p

arrow-down-2.00p (-8.89%)

Prices updated at 07 Nov 2024, 17:07 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Feedback PLC through its subsidiaries is engaged in providing medical imaging tools for clinical decision makers. It develops software and systems that provide techniques and workflows for practitioners involved in medical research and treating patients.

Income statement

20222023
588,5761m
489,255940,721
-3m-3m
-427.00-333.85
-2m-3m
-2m-3m
Sales, General and administrative--
Interest expenses--
Provision for income taxes-392,631-455,909
Operating expenses3m4m
Income before taxes-3m-3m
Net income available to common shareholders-2m-3m
-0.125-0.2614
Net interest income2,01247,868
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.125-0.2614
Free cash flow per share-0.2577-0.0371
Book value/share1.02810.8151
Debt equity ratio--

Balance sheet

20222023
Current assets11m8m
Current liabilities594,126855,449
Total capital14m11m
Total debt--
Total equity14m11m
Total non current liabilities--
Loans--
Total assets14m12m
Total liabilities--
Cash and cash equivalents10m7m
Common stock13m13m

Cash flow

20222023
Cash at beginning of period2m10m
Cash dividends paid--
-2m-494,287
Investments (gains) losses-1m-3m
10m7m
Net income--
-1m-494,287
-1m-
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.